# Lilly rises after boosting 2026 outlook and better-than-expected Q1 2026 financials.

*business · news · 2026-04-30 · Seeking Alpha*

## Key points

- Eli Lilly raised its full-year 2026 financial outlook above prior guidance.
- Lilly reported better-than-expected Q1 2026 financial results.
- Lilly's GLP-1 drug franchise was the main driver of its financial outperformance.
- Eli Lilly shares rose approximately 6% in premarket trading following the announcement.

**Companies:** Eli Lilly and Company, Novo Nordisk
**Countries:** United States, Denmark

[Read the full story on Seeking Alpha](https://seekingalpha.com/news/4582632-eli-lilly-stock-rises-q1-2026-results)

---

Canonical: https://newsio.io/n/55bfc799-e504-4d93-b79b-4540c7726311/lilly-rises-after-boosting-2026-outlook-and-better-than-expected-q1-2026-financi
Summarized by Newsio from Seeking Alpha. https://newsio.io/how-it-works